Pharmacist Identification of New, Diagnostically Confirmed Osteoarthritis

Posted on Lily YushkoPosted in Completed Project

This is a study to determine the feasibility and accuracy of a pharmacist-screening program to identify people with UNDIAGNOSED knee osteoarthritis.

PHIND-OA has been completed and an abstract was accepted at the European League Against Rheumatism Meeting in Amsterdam in late June.

The study, led by Dr. Carlo Marra of the University of British Columbia, was conducted in Save-on-Food Pharmacies in Vancouver and Edmonton.

Publications:

  1. Marra CA, Cibere J, Tsuyuki RT, Soon JA, Esdaile JM, Gastonguay L, Oteng B, Embley P, Colley L, Enenajor G, Kok R. Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis. Arthritis Rheum. 2007 Oct 15;57(7):1238–1244.
  2. Marra CA, Tsuyuki RT, Soon JA, Gastonguay L, Oteng B, Cibere J, et al. Design of a randomized trial of a multidisciplinary intervention for knee osteoarthritis: Pharmacist Initiated Intervention Trial in Osteoarthritis (PhIT-OA). Can Pharm J (Ott) 2008;141:33–38.
  3. Marra CA, Cibere J, Grubisic M, Grindrod KA, Gastonguay L, Thomas JM, Embley P, Colley L, Tsuyuki RT, Khan KM, et al. Pharmacist-initiated intervention trial in osteoarthritis: a multidisciplinary intervention for knee osteoarthritis. Arthritis Care Res. 2012;64(12):1837–1845.